First Step With Singulair® Therapy (0476-323)

Inclusion Criteria: * First time diagnosis of mild asthma symptoms which requires an antiinflammatory controller medication * Patients not controlled with short acting beta2 agonist (sab) therapy (requiring more than one treatment per week but less than 7 per week) * Patients dissatisfied with low dose ics therapy, or patients reluctant to take ics therapy, or patients insufficiently controlled due to non-compliance with low dose ics therapy through out the preceding 6 weeks * Patient's forced expiratory volume in one second (fev1) is \< 80% of predicted value Exclusion Criteria: * Patient on combination therapy * Patient on long acting beta2 agonists * Patient on using moderate to high doses of ICS. (ICS \>250 \&micro g/day flovent\&reg; or equivalent per day)